Lexicon Pharmaceuticals (LXRX) Revenue (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Revenue of $21.1 million for Q1 2026, up 1572.11% year-over-year from $1.3 million in Q1 2025, and up 284.16% quarter-over-quarter from $5.5 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Revenue (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Revenue for 16 consecutive years, with $21.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 1572.11% year-over-year to $21.1 million; the TTM figure through Mar 2026 stood at $69.6 million (up 123.12% YoY), while the FY2025 annual figure was $49.8 million, up 60.24% from the prior year.
- Revenue rose to $21.1 million in Q1 2026 per LXRX's latest filing, from $5.5 million in the prior quarter.
- Across five years, Revenue topped out at $28.9 million in Q2 2025 and bottomed at $35000.0 in Q2 2022.
- Historically, Revenue has averaged $7.9 million across 5 years, with a median of $1.6 million in 2024.
- Annual changes were most pronounced in 2024 — Revenue jumped 3366.58% — and 2025, when it tumbled 79.31%.
- Lexicon Pharmaceuticals' Revenue stood at $35000.0 in 2022, then soared by 2088.57% to $766000.0 in 2023, then surged by 3366.58% to $26.6 million in 2024, then sank by 79.31% to $5.5 million in 2025, then jumped by 284.16% to $21.1 million in 2026.
- Business Quant data shows LXRX's Revenue at $21.1 million in Q1 2026, $5.5 million in Q4 2025, and $14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 692,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 692,000.00 |
| Mar 31, 2026 | 21.10 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 14.18 Mn |
| Jun 30, 2025 | 28.87 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 26.55 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 766,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Dec 31, 2020 | 199,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Mar 31, 2020 | 8.00 Mn |
| Dec 31, 2019 | 8.73 Mn |
| Sep 30, 2019 | 285.91 Mn |
| Jun 30, 2019 | 860,000.00 |